Clinical Trial Update: A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists

View source ↗

Summary

A completed study assessing awareness and perceptions of systemic inflammation and hsCRP as biomarkers among Chinese cardiologists and nephrologists treating pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Chronic Kidney Disease

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | Status: COMPLETED